Amantadine 100 mg is primarily used to treat Parkinson’s disease and the involuntary movements that can develop as a side effect of Parkinson’s medications. It was originally approved as an antiviral for influenza A, but widespread viral resistance has made that use largely obsolete. Today, amantadine is almost exclusively prescribed for movement disorders.
Parkinson’s Disease and Movement Problems
The most common reason doctors prescribe amantadine 100 mg is to help manage Parkinson’s disease symptoms, particularly stiffness, tremor, and difficulty with movement. The standard dose is 100 mg taken twice a day when used on its own. For people with other serious health conditions or those already taking high doses of other Parkinson’s drugs, doctors often start with just 100 mg once daily and increase after one to several weeks if needed. Some patients take up to 400 mg daily in divided doses when lower amounts aren’t enough.
Amantadine plays a particularly valuable role in treating levodopa-induced dyskinesia, the uncontrollable jerking or writhing movements that many Parkinson’s patients develop after years on levodopa (the most common Parkinson’s medication). Randomized controlled trials over the past several years have confirmed that amantadine genuinely reduces these involuntary movements and may also help smooth out the “on-off” fluctuations that make levodopa’s effects unpredictable throughout the day. Extended-release versions of amantadine have been developed specifically for this purpose, taken once daily rather than split into multiple doses.
Drug-Induced Movement Disorders
Amantadine is also FDA-approved for treating extrapyramidal reactions, which are movement side effects caused by certain psychiatric medications, especially older antipsychotics. These reactions can include muscle stiffness, restlessness, involuntary facial movements, and tremors that closely resemble Parkinson’s symptoms. The typical dose is 100 mg twice daily, with some patients requiring up to 300 mg daily in divided doses.
Influenza A: Approved but No Longer Recommended
Amantadine was originally developed and approved to prevent and treat influenza A infections. However, the CDC has not recommended it for flu treatment in the United States for many years. The reason is simple: nearly all circulating seasonal influenza A viruses are now resistant to it. The virus evolved to bypass the mechanism amantadine uses to block viral replication, rendering it ineffective. If your doctor prescribes amantadine today, it is almost certainly for a neurological condition, not the flu.
Off-Label Uses
Doctors sometimes prescribe amantadine for conditions beyond its official approvals. The two most common off-label uses are multiple sclerosis fatigue and traumatic brain injury recovery, though the evidence for both is weaker than many people assume.
For MS-related fatigue, amantadine has been called the “drug of choice” for years despite limited supporting data. A systematic review and meta-analysis of randomized controlled trials found no statistically significant reduction in fatigue severity compared to placebo, and the treatment was associated with a higher likelihood of side effects. This has raised serious questions about whether amantadine should remain a go-to option for MS fatigue.
For traumatic brain injury, the hope has been that amantadine could speed up arousal and cognitive recovery. An updated meta-analysis covering over 1,200 patients found no significant difference in functional recovery between those who received amantadine and those who did not.
How Amantadine Works in the Brain
Amantadine’s effects come from its activity on multiple brain systems simultaneously, which is somewhat unusual for a single drug. It acts as a weak blocker of NMDA receptors, which are involved in transmitting signals between nerve cells using the chemical messenger glutamate. By dialing down excessive glutamate signaling, it helps reduce the abnormal involuntary movements seen in Parkinson’s patients on levodopa.
At the same time, amantadine increases dopamine activity in the brain, the chemical that Parkinson’s disease progressively depletes. It also interacts with noradrenaline and serotonin systems and blocks certain enzymes that break down these chemical messengers. This broad neurochemical profile is likely why it provides modest benefits across several different symptoms rather than dramatically improving any single one.
Common and Uncommon Side Effects
Most side effects of amantadine 100 mg are mild. Nausea, dizziness, insomnia, and difficulty concentrating are the ones patients report most frequently. Dry mouth and constipation can also occur because the drug has mild anticholinergic effects, meaning it partially blocks a chemical messenger involved in digestion and saliva production.
One distinctive side effect is livedo reticularis, a lace-like purplish discoloration of the skin, usually on the legs, sometimes accompanied by swelling. It looks alarming but occurs in less than 1% of Parkinson’s patients taking the drug and typically resolves after stopping the medication. Urinary retention is another uncommon but notable side effect, particularly in older adults.
Kidney Function and Dose Adjustments
Amantadine is cleared from the body almost entirely by the kidneys, so reduced kidney function means the drug stays in your system longer and can build up to problematic levels. Dose adjustments are based on how well your kidneys filter waste. People with moderately reduced kidney function may take 100 mg daily instead of twice daily. Those with more significant impairment might take 100 mg every other day, and people with severe kidney disease or on dialysis may only take a dose once a week. Your doctor will typically check kidney function before starting the medication, and older adults are started at lower doses as a precaution since kidney function naturally declines with age.
What to Expect When Starting
If you’re starting amantadine for Parkinson’s disease, improvements in stiffness and movement typically begin within the first few days to a week, though it may take several weeks to see the full effect on dyskinesia. Some people notice that the benefits seem to fade after several months of continuous use, a phenomenon doctors sometimes address by briefly stopping the medication and restarting it.
Stopping amantadine abruptly can cause a rebound worsening of Parkinson’s symptoms, so tapering off gradually is the standard approach. This is especially important for patients taking it alongside levodopa, where sudden discontinuation can trigger a sharp increase in dyskinesia or even a dangerous condition resembling neuroleptic malignant syndrome, with high fever, muscle rigidity, and confusion.